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Abstract OAS1 is the small form and OAS2 is the medium
form of the human interferon-induced 2P-5P oligoadenylate
synthetases. The p42 isoform of OAS1 and the p69 isoform of
OAS2 have been expressed in insect cells and purified to give
pure, highly active 2P-5P oligoadenylate synthetase. The catalysis
of 2P-5P oligoadenylate synthesis is strictly dependent on double-
stranded RNA and magnesium ions. We have examined the effect
of a series of divalent metal ions: copper, iron and zinc ions
strongly inhibited the enzymatic activity, cobalt and nickel ions
were partly inhibitory whereas calcium and manganese ions were
without effect. However, manganese ions can replace magnesium
ions as activator. The inhibitory effect of zinc ions was
characterised in detail. The inhibitory constants of Zn2+ were
estimated to be 0.10 mM for OAS1p42 and to 0.02 mM for
OAS2p69. Cross-linking experiments showed that zinc ions can
control the oligomerisation by enhancing the formation of
tetrameric forms of OAS1p42 ß 2001 Federation of European
Biochemical Societies. Published by Elsevier Science B.V. All
rights reserved.
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1. Introduction
The 2P-5P oligoadenylate synthetases (OAS) are a family of
interferon-induced antiviral enzymes. They catalyse the oligo-
merisation of ATP into 2P-5P-linked oligoadenylates (2-5A),
which in turn serve as activators of a latent endoribonuclease,
named RNase L [1]. Binding of 2-5A to RNase L leads to the
dimerisation and activation of this enzyme [2]. Activation of
RNase L leads to degradation of a range of RNA molecules
within the a¡ected cell, followed by a decrease in cellular
protein synthesis [3].
In humans there are three genes encoding functional 2P-5P
oligoadenylate synthetase, OAS1, OAS2 and OAS3, and one
gene encoding an OAS-like protein, OASL [4]. The OAS1
gene, which encodes the small OAS, consists of one basal
OAS unit, which is repeated twice in the OAS2 gene (encoding
medium OAS) [5] and three times in the OAS3 gene (encoding
the large OAS) [6]. The OASL p59 protein has one OAS
domain and a carboxy-terminal domain homologous to ubiq-
uitin [7,8]. The transcription of all four members of the OAS
gene family is strongly induced by interferon-K and to a lesser
extent by interferon-Q [9].
The OAS proteins are a unique family of enzymes, as they
are the only known proteins to catalyse the formation of 2P-
to 5P-linked oligonucleotides. However, OAS is produced as a
latent enzyme, which upon interaction with an appropriate
RNA activator becomes catalytically active [10]. None of
the OAS proteins share signi¢cant sequence homology with
other known proteins. Nevertheless, a combination of molec-
ular modelling and mutagenesis studies has shown that the
architecture of the active site for the nucleotidyl transferase
reaction is similar to that known for 3P-5P nucleotidyl trans-
ferases [11]. Three conserved glutamates are assumed to co-
ordinate the catalytic magnesium ion, in a manner similar to
that seen in many RNA and DNA polymerases. The mecha-
nism by which RNA activates the enzyme is still largely un-
known, but the basal activity of OAS in the absence of an
RNA activator is negligible [10].
The involvement of OAS in establishing the antiviral state
induced by interferon has been con¢rmed through several in-
dependent experiments. Expression of cDNA encoding OAS1
in mammalian cell lines resulted in an increased resistance
towards picornavirus infection. Furthermore the level of
OAS expression in di¡erent clones correlated with the antivi-
ral e¡ect observed [12]. Later similar results were obtained
with OAS2 [13,14]. Expression of OAS1 cDNA together
with RNase L cDNA in transgenic plants resulted in increased
resistance towards viral infection. In contrast, expression of
either OAS1 or RNase L alone had no e¡ect on the antiviral
resistance of the plant, demonstrating the need for both genes
in the antiviral response [15,16]. Recent data also suggest that
activation of the 2-5A system in human cells is involved in at
least two pathways leading to apoptosis of the a¡ected cells
[17,18]. It appears reasonable that leading virus-infected cells
into apoptosis can protect the host against spread of the in-
fection.
Zinc has been proposed to block apoptosis in human cells
and several studies have suggested a role for OAS in the in-
duction of apoptosis. Furthermore, the second enzyme in the
2-5A system, RNase L, is also inhibited by Zn2 ions [2].
Mg2 ions are required for the enzymatic activity of the
OAS proteins, but can to a certain extent be replaced by
Mn2 [4,19]. Other metal ions of the same range are thought
to be inhibitory, but the data are rather di⁄cult to assign to
the forms of OAS as they are known now.
In this study we are examining the e¡ect of a number of
divalent cations on the activity of the OAS1 and the OAS2
proteins, which have been expressed in insect cells. The oligo-
meric structure of OAS1 (tetramer) and OAS2 (dimer) is im-
portant for the enzymatic activity [20^22], and here we dem-
onstrate that this can be controlled by Zn2 and other similar
metal ions.
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2. Materials and methods
2.1. Expression and puri¢cation of 2P-5P oligoadenylate synthetase
Human OAS1, p42 isoform: the protein was expressed using the
baculovirus system as described elsewhere [10]. 200 ml HiFive cells,
infected with the recombinant virus at a multiplicity of infection of 10,
were harvested 3 days post infection. Cell pellets were resuspended in
20 ml of lysis bu¡er (1% (v/v) Nonidet P40, 50 mM HEPES pH 6.8,
300 mM NaCl, 5 mM 2-mercaptoethanol and protease inhibitor cock-
tail (Complete1, Boehringer Mannheim)) and lysis was performed for
10 min on ice with gentle vortexing. The lysate was centrifuged at
10 000Ug for 20 min at 4‡C and the supernatant was applied to 5 ml
HiTrap SP column (Amersham Pharmacia Biotech), equilibrated with
bu¡er A (25 mM HEPES pH 6.8 plus 5% glycerol). After loading of
the sample, the column was washed with bu¡er A at a £ow of 1 ml/
min until the UV280 absorption was stable. Bound proteins were
eluted with a linear gradient of NaCl from 0 to 0.6 M. 1 ml fractions
were collected and samples (5 Wl) from every second fraction were
tested for OAS activity, using the rapid pyrophosphate assay [23].
Fractions containing enzymatically active OASp42 were pooled and
ammonium sulphate was added to a ¢nal concentration of 1.5 M and
then applied to a HR 10/10 (Pharmacia Amersham Biotech) column
packed with phenyl-Sepharose (phenyl-Sepharose 6 FF, Pharmacia
Amersham Biotech), equilibrated with bu¡er B (50 mM HEPES pH
6.8, 50 mM NaCl, 1 mM EDTA) plus 1.5 M ammonium sulphate.
The column was washed with bu¡er B plus ammonium sulphate until
the UV280 was stable, then again with bu¡er B without ammonium
sulphate until the UV280 was stable. Bound proteins were eluted with
a linear gradient of an increasing concentration of ethylene glycol (0^
50%) in bu¡er B. Fractions containing enzymatic activity were com-
bined and analysed by SDS^PAGE. The eluted protein was then ex-
cessively (48 h) dialysed against bu¡er E without EDTA at 4‡C.
Puri¢ed protein was stored in aliquots at 380‡C. Protein quanti¢ca-
tion was done using the Bio-Rad protein assay reagent according to
the instructions of the manufacturer.
Puri¢cation of the OAS2 protein (p69 isoform) was done as de-
scribed [11,24].
2.2. 2P-5P Oligoadenylate synthetase assay using PEI-thin layer
chromatography
Activity assays were performed as follows: 4 Wl of bu¡er C, 4 Wl of
OAS in bu¡er B minus EDTA, 10 Wl bu¡er D and 2 Wl of a 10U stock
of the indicated metal or water. Incubation was performed in thin-
walled 100 Wl PCR tubes in an incubator at 37‡C. Solutions: bu¡er C
(20 mM Tris^HCl pH 7.5, 50 mM Mg(OAc)2, 25 mM ATP pH 7.5,
1 mM dithiothreitol and 10% (v/v) glycerol, 0.025 mCi [K-32P]ATP/Wl).
Bu¡er D (10 mM KOAc, 5 mM Mg(OAc)2, 20 mM Tris^HCl pH 7.5,
100 mg/ml poly I poly C (Amersham Pharmacia Biotech)). Separation
of ATP and the 2-5A products was performed by thin layer chroma-
tography (TLC) on poly(ethylene)imine^cellulose plates according to
[25].
Separated reaction products were visualised either by autoradiog-
raphy using X-ray ¢lms or using a Phosphoimager (Personal Molec-
ular Imager FX, Bio-Rad). Quanti¢cation of spots was done using
Imagequant software with the Phosphoimager. Activity was calculated
as the fraction of ATP converted into 2-5A. Values were corrected for
background noise by normalising to a blank lane without enzyme.
For determination of IC50 values, a minimum of three experiments
were carried out for each data point. The data were ¢tted to the
following model: f(I) = maxAU(IC50n/(ICn50+I
n)) with f(I) as the activ-
ity at a given concentration of inhibitor, maxA as the activity without
any addition of inhibitor, I as the inhibitor concentration, IC50 as the
concentration of inhibitor required for half-maximum inhibition and n
as the Hill coe⁄cient. The data were ¢tted to this model using non-
linear regression, giving the maxA and IC50 values for each data set.
In the next step, the experimentally observed activities in each data set
were normalised to the corresponding maximum activity. The mean
and the mean standard deviation of these normalised values were
calculated for each data point, and plotted against the Zn2 concen-
tration.
2.3. Immunoblotting
Proteins were separated by 7.5% SDS^PAGE and blotted onto
polyvinylidene di£uoride (Immobilon-P, Millipore) membranes. Blots
were blocked overnight in phosphate-bu¡ered saline containing 5%
dried milk. Blots were probed with a rabbit polyclonal antibody raised
against a synthetic peptide corresponding to peptide B from OAS1
used by [22], washed and probed with a secondary antibody (goat
anti-rabbit, horseradish peroxidase-conjugated). The blot was ¢nally
developed with the enhanced chemiluminescence reagent (ECL, Amer-
sham Pharmacia Biotech) according to the instructions of the manu-
facturer.
Fig. 1. Inhibition of OAS1 (p42 isoform) and OAS2 (p69 isoform)
by various divalent metal ions. Standard 2P-5P oligoadenylate syn-
thetase assays were performed in the presence of 1 mM of the indi-
cated divalent metal ions or water (only Mg2). All metals were
added as chloride salts. ATP was separated from the produced 2-
5As using thin layer chromatography.
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2.4. Protein cross-linking with dimethyl suberimidate (DMS)
Chemical cross-linking was done as described by [26] using DMS as
the cross-linking reagent. The reaction mixture contained 5 Wl OAS
(20 Wg/ml)+3 Wl DMS (40 Wg/ml), and metal ions at the indicated
concentration, in a total volume of 10 Wl. Incubation was performed
for 1 h at room temperature. Reactions were stopped by addition of
10 Wl of sample-loading bu¡er containing 4% SDS and boiling at 95‡C
for 10 min followed by SDS^PAGE and immunoblotting.
3. Results
3.1. Inhibition of OAS1 and OAS2 by various divalent
metal ions
In order to establish the e¡ect of divalent metal ions on the
OAS we have tested the in£uence of di¡erent chloride salts of
these metals on the activity of the OAS1 and OAS2 proteins
(Fig. 1). The various metals were added to standard OAS
activity reactions at a ¢nal concentration of 1 mM, and the
formation of 2-5A oligomers was monitored after separation
by thin layer chromatography. Transitions state metals such
as copper, iron and zinc showed an almost complete inhibi-
tion, whereas cobalt and nickel gave a strong but somewhat
weaker inhibition. Calcium gave a weak inhibition and man-
ganese had no signi¢cant in£uence.
We therefore chose to investigate the inhibition exerted by
zinc in further detail. We performed dose^response experi-
ments with both the OAS1 (Fig. 2) and OAS2 enzymes, and
determined the IC50 values (Figs. 3 and 4). Both enzymes were
strongly inhibited by Zn2, with an IC50 value of 0.10 mM for
OAS1 (Fig. 3) and an IC50 of 0.02 mM for OAS2 (Fig. 4).
Estimation of the Hill coe⁄cient revealed a clear di¡erence
between the two enzymes (Figs. 3 and 4). We estimated the
Hill coe⁄cient for the Zn2 inhibition of OAS2 to be approx-
imately 1, indicating a non-co-operative binding of Zn2 to
OAS2. In contrast, the inhibition of OAS1 by Zn2 had a Hill
coe⁄cient of 1.8, indicating co-operative binding of Zn2 with
at least two binding sites on the molecule.
3.2. Zn2+ leads to oligomerisation of OAS1
OAS1 has previously been reported to exist in an oligomeric
state [27]. We therefore chose to examine the in£uence of
Zn2 on the oligomeric state of OAS1. The oligomerisation
was measured by chemical cross-linking of the OAS1 protein
under conditions identical to the ones used for activity assays.
The reaction mix was preincubated for 10 min before addition
of the cross-linker DMS. Oligomers were then separated by
SDS^PAGE and detected by Western blots (Fig. 5). The
amount of oligomeric protein clearly increases with increasing
Zn2 concentrations and the concentration dependence of the
cross-link with regard to Zn2 correlates with the concentra-
tion required for inhibition. In the cross-linking experiment
Fig. 2. Dose^response experiment for OAS1 with increasing concentrations of zinc ions. ZnCl2 was added to standard 2P-5P oligoadenylate syn-
thetase assays. The amount of 2-5A produced was quanti¢ed and normalised to the ATP spot.
Fig. 3. Dose^response curve for OAS1. The mean activity of at least
three independent measurements was plotted versus the ZnCl2 con-
centration. The IC50 and Hill coe⁄cient were estimated using non-
linear regression analysis.
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we used a low concentration of the cross-linker DMS, in order
to avoid extensive cross-linking which leads to clotting in the
gel slots. This means that only a fraction of the oligomeric
protein will cross-link under the conditions used here. If stan-
dard concentrations of DMS were used together with a Zn2
concentration of 1 mM, an almost complete cross-linking
would be observed. However, under these conditions it was
not possible to separate the protein properly in the gel and
most of the protein would remain in the stacking gel (data not
shown). Without the addition of metal in addition to Mg2, a
weak cross-linking is observed.
In order to rule out the possibility that Zn2 activates the
cross-linking process rather than inducing oligomerisation of
OAS1, we performed cross-linking of creatine kinase in the
presence or absence of zinc. Rabbit creatine kinase forms a
tetrameric complex, which will cross-link partially under the
conditions used here. We examined if Zn2 would in£uence
the e⁄ciency of the cross-linking reaction. There was no e¡ect
of zinc ions on the DMS cross-linking reaction with creatine
kinase (data not shown). In a similar experiment with OAS2
the eventual oligomerised protein was below the detection
limit (data not shown).
4. Discussion
4.1. Inhibition of 2P-5P oligoadenylate synthetase by divalent
metal ions
We have identi¢ed a number of metals that strongly inhibit
the activity of the OAS1 as well as the OAS2 protein, and we
have examined the e¡ect of zinc ions in further detail. Addi-
tion of copper, iron or zinc ions at a concentration of 1 mM
inhibited the enzyme almost completely leaving less than 5%
of the original activity. It should be stated that 10 mM Mg2
is present for full 2-5A synthetase activity and that 1 mM
Mg2 will only give 10% of full activity. Cobalt and nickel
ions also showed an inhibition at the same concentration,
although roughly 15% of the original activity remained. The
primary ligands of these metals in proteins are the nitrogen
atom of the imidazole ring in histidine, and the thiol group of
cysteine. Co-ordination of Zn2 by the carboxyl groups of the
side chains of aspartic and glutamic acids can occur even
though this is less common. We have also con¢rmed that
Mg2 and Mn2 are activators and that Ca2 has no e¡ect.
Even though both OAS1 and OAS2 are strongly inhibited
by zinc and by other metal ions as well, only OAS1 displays
some co-operativity in the metal ion-mediated inhibition. No
structural information is yet available on the OAS proteins,
and hence we do not know the zinc-binding site. The Zn2-
induced oligomerisation seen with OAS1 suggests that binding
of Zn2 to the protein leads to a conformational change with-
in the OAS1 protein which promotes the oligomerisation.
Zinc has previously been proposed to inhibit apoptosis
under certain conditions and zinc is also capable of inhibiting
the important proapoptotic protein caspase 3 [28]. The inter-
cellular concentration of Zn2 has been estimated to be
around 0.10 mM [29], but the concentration of free Zn2
might be as low as 0.01 mM. However, iron also exists in
signi¢cant amounts within the cell and might play a role
under conditions with high levels of free iron ions. We can
only speculate that the inhibition of OAS1 and 2 described
here represents a mechanism for cellular regulation of OAS
activity in addition to the regulation by RNA.
4.2. Zn2+-mediated oligomerisation of OAS1
Mutational studies have shown that an invariant cysteine
found in all OAS proteins, except that of Geodia cydonium, is
crucial for the enzymatic activity as well as important for the
ability to form multimers [11,20]. When a three amino acid
motif including this cysteine was mutated to alanine, OAS1
(the p48 isoform) lost the ability to form tetramers and OAS2
(the p69 isoform) lost its ability to form dimers. Both the
OAS1 and the OAS2 proteins were inactivated by this muta-
tion. These observations lead to the conclusion that the for-
mation of oligomers is required for the activity of OAS1 and
OAS2. The authors isolated monomeric and tetrameric OAS1
(p48 isoform) protein by gel ¢ltration, and demonstrated that
the active protein was found in the tetrameric fraction [20].
Fig. 4. Dose^response curve for OAS2. Experiments were performed
as in Fig. 3.
Fig. 5. Zinc promotes the oligomerisation of OAS1. DMS cross-
linking of p42 under normal assay condition, using increasing
amounts of zinc ions. After cross-linking the proteins were sepa-
rated on SDS^PAGE and detected by immunoblotting. A clear in-
crease in multimeric OAS1 (p42 isoform) is seen as increasing con-
centrations of zinc ions are used.
FEBS 25314 11-10-01
R. Hartmann et al./FEBS Letters 507 (2001) 54^58 57
However, the isolation of monomeric and fully active human
OAS1 (p42 isoform) protein by glycerol gradient has been
reported [21]. The protein used in this study was isolated
from insect cells infected with a recombinant baculovirus ex-
pressing the gene of interest. Human OAS1 protein, p42 iso-
form, produced in insect cells is mainly monomeric, with 5^
20% of multimeric protein. However, in our hands the mono-
meric p42 protein can be isolated with no loss of activity by
gel ¢ltration (data not shown). Furthermore, we have repro-
duced the results obtained with the OAS1 protein (both the
Zn2 inhibition and the Zn2-induced cross-linking) using a
porcine orthologue of the human OAS1. This porcine protein
is produced in Escherichia coli and is exclusively monomeric
as judged by gel ¢ltration.
There are several possible explanations for the discrepancies
discussed above, inherent di¡erences between the p42 and p48
isoforms and the di¡erent assay methods used. Arundhati
Ghosh and her colleagues [20] used enzyme immobilised on
agarose beads whereas we used soluble enzyme. Nevertheless,
we have demonstrated that Zn2 leads to the formation of
inactive multimers of the OAS1 enzyme. As noted above,
the invariant cysteine found in the carboxy-terminus of the
OAS proteins is involved in the multimerisation of both the
OAS1 and OAS2 proteins as well as being important for the
activity of these proteins. Since Zn2 leads to both inhibition
of both OAS1 and OAS2, and the multimerisation of OAS1,
it might interact with this cysteine and disorders its normal
function.
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